Company news
Optibiotix Health Plc (LSE:OPTI) news
Optibiotix Health Plc news releases on 6ix. Latest, Jan 12, 2021: Change of broker
Press releases — page 3
Change of broker
January 12, 2021
Research study
January 11, 2021
Proposed Director appointment and Director change
December 9, 2020
License and supply agreement with Genuine Health
November 18, 2020
Launch of weight management products
October 12, 2020
Head of Quality & Operations appointment
October 8, 2020
Exclusive distribution agreement
October 6, 2020
FDA Investigational New Drug authorisation
October 2, 2020
License agreement for SlimBiome® Medical in the US
September 22, 2020
Distributor agreement with Ayalla Marketing
September 17, 2020
SweetBiotix sweet fibres agreement
September 15, 2020
Scientific and commercial development update
August 11, 2020
Extension of terms for OptiBiome with OptiPharm
August 5, 2020
Extension of terms for WellBiome with Maxum Foods
July 30, 2020
Extension of terms for WellBiome with Agropur
July 23, 2020
Extension of terms, territories and products
July 16, 2020
Extension of terms for WellBiome
July 14, 2020
Distribution agreement with Actial Farmaceutica
July 1, 2020
Launch of WellBiome
June 29, 2020
Notice of AGM
June 17, 2020
Exercise of Warrant
June 3, 2020
Grant of Options
June 2, 2020
Cambridge Commodities appointment as distributor
June 1, 2020
Launch of SlimBiome gummies in USA
May 20, 2020
Exclusive distribution agreement with MAXCARE Inc
May 11, 2020
Distribution of products in China and Hong Kong
May 5, 2020
Non-exclusive agreement with Smart For Life
May 4, 2020
Placing and Related Party Transaction
April 17, 2020
SlimBiome® contract manufacturing agreement
April 6, 2020
Exclusive licence agreement for OptiBiome®
March 31, 2020
Extension of territories for GoFigure®
March 24, 2020
Change of accounting year end
March 23, 2020
Distribution Agreement for SlimBiome® Medical
March 17, 2020
New partner for LPLDL® in Bulgaria
March 12, 2020
Extension of LPLDL® supply agreement with SACCO
March 11, 2020
Marketing update
February 25, 2020
Distributor agreement for LPLDL®
February 17, 2020
Extension of LPLDL® into Dairy Products
February 12, 2020
Launch of SlimBiome® in North America
January 31, 2020
Extension of term and territories for products
January 28, 2020
Launch of LPLDL® product with AlfaSigma
January 27, 2020
LPLDL® reduces high blood pressure
January 8, 2020
Launch of SlimBiome® range in Holland & Barrett
January 7, 2020
SlimBiome® distribution agreement for Germany
December 19, 2019
Anthem BioPharma launches two products in India
December 17, 2019
Distribution agreement for CholBiome®x3
December 9, 2019
GoFigure® and SlimBiome® commercial updates
December 6, 2019
SlimBiome® Medical update
December 5, 2019
Appointment of European Sales Leader - ProBiotix
December 4, 2019
LPLDL® Pharmaceutical GMP process validation
October 9, 2019